(Q33357141)
Statements
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients (English)
Francisco Cervantes
Juan-Carlos Hernández-Boluda
Juan-Luis Steegmann
Eulogio Conde
Alberto Alvarez-Larrán
Javier López-Jiménez
Santiago Osorio
Lucía Villalón
Mireia Camós
Javier García-Conde
Jesús Odriozola